Pages that link to "Item:Q3445286"
From MaRDI portal
The following pages link to Designs for Single- or Multiple-Agent Phase I Trials (Q3445286):
Displaying 13 items.
- Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach (Q93669) (← links)
- Adaptive isotonic estimation of the minimum effective and peak doses in the presence of covariates (Q419309) (← links)
- Bayesian phase I/II adaptively randomized oncology trials with combined drugs (Q641145) (← links)
- A phase I dose-finding study based on polychotomous toxicity responses (Q1708945) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Cumulative cohort design for dose-finding (Q2455719) (← links)
- Continual reassessment method for partial ordering (Q2893418) (← links)
- A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents (Q3064270) (← links)
- A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents (Q3183236) (← links)
- A Parallel Phase I/II Clinical Trial Design for Combination Therapies (Q5459586) (← links)
- Determining a Maximum‐Tolerated Schedule of a Cytotoxic Agent (Q5714615) (← links)
- A nonparametric Bayesian method for dose finding in drug combinations cancer trials (Q6626759) (← links)
- Dual-agent dose-finding in phase I clinical trial -- an extension of rapid enrollment design (Q6652600) (← links)